A company insider recently sold 668 shares of Medpace Holdings Inc [MEDP]. Should You Sale?

Roman Campbell

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Medpace Holdings Inc shares valued at $394,581 were sold by Troendle August J. on Dec 03 ’25. At $590.69 per share, Troendle August J. sold 668 shares. The insider’s holdings dropped to 646,184 shares worth approximately $369.53 million following the completion of this transaction.

Also, Troendle August J. sold 23,178 shares, netting a total of over 13,750,348 in proceeds. Following the sale of shares at $593.25 each, the insider now holds 652,550 shares.

Before that, Troendle August J. had sold 5,698 shares from its account. In a trade valued at $3,364,498, the CEO traded Medpace Holdings Inc shares for $590.47 each. Upon closing the transaction, the insider’s holdings decreased to 5,698 shares, worth approximately $369.91 million.

As published in their initiating research note from BMO Capital Markets on November 13, 2025, Medpace Holdings Inc [MEDP] has been a Market perform and the price target has been revised to $600. Analysts at Barclays downgraded the stock from ‘”an Equal weight”‘ to ‘”an Underweight”‘ outlook in a report released in early October. As of September 03, 2025, Rothschild & Co Redburn has decreased its “Buy” rating to a “Neutral” for MEDP. Earlier on July 29, 2025, UBS downgraded its rating. Their new recommendation was “a Sell” for MEDP stock which previously was a “a Neutral”.

Analyzing MEDP Stock Performance

On last trading session, Medpace Holdings Inc [NASDAQ: MEDP] rose 0.38% to $571.86. The stock’s lowest price that day was $564.76, but it reached a high of $572.87 in the same session. During the last five days, there has been a surge of approximately 2.65%. Over the course of the year, Medpace Holdings Inc shares have jumped approximately 69.55%. Shares of the company reached a 52-week high of $626.26 on 11/25/25 and a 52-week low of $250.05 on 04/22/25.

Support And Resistance Levels for Medpace Holdings Inc (MEDP)

According to the 24-hour chart, there is a support level at 566.79, which, if violated, would cause prices to drop to 561.72. In the upper region, resistance lies at 574.90. The next price resistance is at 577.94. RSI (Relative Strength Index) is 51.85 on the 14-day chart, showing neutral technical sentiment.

Is Medpace Holdings Inc subject to short interest?

Stocks of Medpace Holdings Inc saw a sharp rise in short interest on 2025-11-28 jumping by 76295.0 shares to 1.37 million. Data from Yahoo Finance shows that the short interest on 2025-10-31 was 1.3 million shares. A jump of 5.55% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.28 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.28.

Which companies own the most shares of Medpace Holdings Inc (MEDP)?

In terms of Medpace Holdings Inc share price expectations, FactSet research, analysts set an average price target of 584 in the next 12 months, up nearly 2.51% from the previous closing price of $569.7. Analysts anticipate Medpace Holdings Inc stock to reach 655 by 2025, with the lowest price target being 525. In spite of this, 9 analysts ranked Medpace Holdings Inc stock as Buy at the end of 2025. On July 23, 2025, TD Cowen assigned a price target of “a Sell” to the stock and downgraded coverage with a $366.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.